Kolon TissueGene, Inc. (950160.KQ) — Stock Score Summary

Kolon TissueGene, Inc. (950160.KQ) has a MoatMap StockRank of 1/100 based on Quality (3/100), Value (19/100), and Momentum (47/100) factor scores. The current signal is STRONG SELL.

Key Financial Metrics

Price$67.21
Market Cap$5.5B
Price/Book132.60
Return on Equity-300.5%
Return on Invested Capital-281.8%
Debt/Equity124.16
Gross Margin13.3%
Operating Margin-432.7%
Free Cash Flow$-61K

Frequently Asked Questions

What is Kolon TissueGene, Inc.’s (950160.KQ) StockRank?
MoatMap’s StockRank for Kolon TissueGene, Inc. (950160.KQ) is 1/100, with a Strong Sell signal. It is a composite of Quality (3), Value (19), and Momentum (47) factor ranks across MoatMap’s 19,000+ stock universe.
Does Kolon TissueGene, Inc. have an economic moat?
Kolon TissueGene, Inc. (950160.KQ) has a Quality factor score of 3/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Kolon TissueGene, Inc. a buy, hold, or sell?
MoatMap’s current signal for Kolon TissueGene, Inc. (950160.KQ) is Strong Sell, based on a StockRank of 1/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.